Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein

Abstract Severe COVID-19 is characterized by thrombo-inflammatory processes within the lung microvasculature. In pursuit of effective treatments, clinical studies explored mesenchymal stromal cells (MSCs) as a promising approach due to their anti-inflammatory, immunomodulatory, and regenerative prop...

Description complète

Détails bibliographiques

Auteurs principaux:	Anna Pezzotta, Alessandra Bovio, Barbara Imberti, Monica Locatelli, Daniela Corna, Domenico Cerullo, Sara Gastoldi, Ariela Benigni, Giuseppe Remuzzi, Marina Morigi, Luca Perico
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-07-01
Collection:	Stem Cell Research & Therapy
Sujets:	COVID-19 Spike protein 1 Complement Endothelial dysfunction Glycocalyx Thrombo-inflammation
Accès en ligne:	https://doi.org/10.1186/s13287-025-04472-6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!